BridgeMD
New treatment option for Constipation - Functional
Official title Chronic Ingestion of Fructooligosaccharide and Psyllium on Intestinal Transit in Women With Functional Constipation: A Randomized Crossover Trial
ClinicalTrials.gov ID: NCT07202481
What this study is testing
- What it's testing
- The goal of this clinical trial is to evaluate the effect of dietary fibers in the treatment of functional constipation in women. It will also assess the potential side effects associated with fiber consumption.
- You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 59, women only
You may be able to join if
- Female participants aged 18-59 years.
- Willingness to sign the Informed Consent Form .
- No restrictions on the consumption of egg or gluten.
- No history or diagnosis of gastrointestinal diseases other than functional constipation.
- Non-smokers.
You likely can't join if
- Diagnosis of diabetes, severe hyperthyroidism, or hypothyroidism.
- Use of opioid medications.
- Delayed gastric emptying at 4 hours during the placebo period (participants meeting this criterion will be excluded from final analysis).
See the full eligibility criteria
- Female participants aged 18-59 years.
- Willingness to sign the Informed Consent Form .
- No restrictions on the consumption of egg or gluten.
- No history or diagnosis of gastrointestinal diseases other than functional constipation.
- Non-smokers.
- No use of prebiotics, probiotics, synbiotics, or antibiotics at least 10 days prior to the study.
- No previous surgery affecting gastrointestinal transit.
- Willingness to discontinue the use of laxatives at least 4 days prior to scintigraphic imaging.
- Participants who do not consume adequate dietary fiber (25-30 g/day) as assessed by dietary recall.
- No confirmed or suspected pregnancy during the study.
- No self-reported menopause
- Diagnosis of diabetes, severe hyperthyroidism, or hypothyroidism.
- Use of opioid medications.
- Delayed gastric emptying at 4 hours during the placebo period (participants meeting this criterion will be excluded from final analysis).
The study team makes the final eligibility decision.
Where it's taking place
- Belo Horizonte, Minas Gerais, Brazil
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 59 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Belo Horizonte, Minas Gerais, Brazil. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.